Literature DB >> 2152502

Thymic dendritic cells: phenotype and function.

P J Fairchild1, J M Austyn.   

Abstract

Interdigitating (IDC) cells of the thymus have been characterized in situ by their ultrastructure and phenotype. Thymic dendritic cells (DC), thought to represent their in vitro correlate, resemble splenic DC in their ability to initiate peripheral T cell responses. In vivo, however, DC of the thymus have been implicated in tolerance induction, although at one time they were thought to impart MHC-restriction on developing T cells. Our present understanding of these areas is reviewed here. An in vitro model has been developed to address directly the function of DC in the thymus. Mature DC and immature thymocytes migrate into deoxyguanosine-treated thymus lobes where they adopt a reciprocal distribution, DC homing primarily to the medulla while the thymocytes remain in the cortex. These observations support the close relationship between thymic DC and IDC and provide a powerful tool to examine the role of DC in thymocyte ontogeny.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152502     DOI: 10.3109/08830189009056629

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  15 in total

1.  The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells.

Authors:  D Vremec; M Zorbas; R Scollay; D J Saunders; C F Ardavin; L Wu; K Shortman
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

2.  Developmental changes predispose the fetal thymus to positive selection of CD4+CD8- T cells.

Authors:  P J Fairchild; J M Austyn
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

3.  IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals.

Authors:  Honorio Torres-Aguilar; Carmen Sánchez-Torres; Luis J Jara; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2010-06-11       Impact factor: 8.317

Review 4.  Dendritic cells and immunity against cancer.

Authors:  K Palucka; H Ueno; J Fay; J Banchereau
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 5.  Dendritic cell subsets as vectors and targets for improved cancer therapy.

Authors:  Karolina Palucka; Hideki Ueno; Lee Roberts; Joseph Fay; Jacques Banchereau
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 6.  Dendritic cells: are they clinically relevant?

Authors:  Karolina Palucka; Hideki Ueno; Lee Roberts; Joseph Fay; Jacques Banchereau
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

7.  Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.

Authors:  H C O'Neill; K Ni
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

8.  Thymic dendritic cells are primary targets for the oncogenic virus SL3-3.

Authors:  C H Uittenbogaart; W Law; P J Leenen; G Bristol; W van Ewijk; E F Hays
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Recovery from Friend disease in mice with reduced major histocompatibility complex class I expression.

Authors:  K J Hasenkrug; G J Sprangrude; J Nishio; D M Brooks; B Chesebro
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  The effects of in vivo cyclosporin A administration on rat thymic dendritic cells.

Authors:  J G Damoiseaux; L J Beijleveld; P J van Breda Vriesman
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.